Companion Medical Receives FDA Clearance for InPen Insulin B
Released: Doctor's guide to managing the Coronavirus/COVID19 outbreakWatch VideoDownload SlidesReleased: Doctor's guide to managing the Coronavirus/COVID19 outbreakWatch VideoDownload Slides
Companion Medical announced that it received FDA clearance for its InPen bolus calculator for fixed dosing and meal estimation.

Only 42% of people living with Type 1 diabetes count carbohydrates to determine their mealtime insulin dose, according to the company. Incorrect carb counting and insulin dosages often result in hypo- and hyperglycemia.

The bolus calculator is designed to remove the guesswork from insulin dosing for those with either Type 1 or Type 2 insulin-dependent diabetes, by taking into consideration each user’s current glucose level and “active insulin,” the calculation of the amount of insulin still lowering glucose from previous bolus doses.
The bolus calculator is a part of the larger InPen system, which includes a smartpen and Bluetooth-connected app that helps patients calculate insulin doses, issue dose reminders, track active insulin, and send reports to caregivers.

Mike Mensinger, CTO, and co-founder at Companion Medical said that with the new calculator modes, InPen provides recommendations automatically based on their current glucose level and factoring in active insulin to safely allow correction of high blood glucose between meals.”

S●●●●●●y V●●s and 1 others like this
Dr. S●●●●●m S●●●●y P●●●●●l
Dr. S●●●●●m S●●●●y P●●●●●l Family Medicine
Thank you for info PlexusMd.
Mar 4, 2020Like